Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-23-005145
Filing Date
2023-02-28
Accepted
2023-02-28 16:34:50
Documents
6
Effectiveness Date
2023-02-28

Document Format Files

Seq Description Document Type Size
1 S-8 form_s-8_2023_evergreen.htm S-8 169221
2 EX-5.1 vir-ex5_1.htm EX-5 22211
3 EX-23.1 vir-ex23_1.htm EX-23 5358
4 EX-FILING FEES vir-exfiling_fees.htm EX-FILING FEES 76612
5 GRAPHIC img2017497_0.jpg GRAPHIC 1660
6 GRAPHIC img2017497_1.jpg GRAPHIC 112846
  Complete submission text file 0000950170-23-005145.txt   432417
Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

EIN.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270108 | Film No.: 23686130
SIC: 2836 Biological Products, (No Diagnostic Substances)